Companies
/Healthcare
Revvity Inc
$142.11
▼ $1.20 (−0.84%) today
Markets closed · 8:17pm ET
24/7 Wall St. View
Fundamentals
Market Cap
$16.0B
P/E Ratio
68.9
Dividend Yield
0.19%
Profit Margin
8.2%
Revenue (TTM)
$2.9B
EPS (TTM)
$2.08
52-Week Range
$81 – $150
Street Target
$128.47
About Revvity
Revvity Inc, formerly known as PerkinElmer, is a global provider of health sciences solutions, technologies, and services. With a focus on Life Sciences and Diagnostics, the company offers a wide range of products including instruments, reagents, software, and services for genetic disorder detection and infectious disease testing. Its innovative technologies support genomic workflows in oncology, immunodiagnostics, and drug discovery. Serving a diverse clientele, from pharmaceutical companies to academic institutions, Revvity is a key player in advancing healthcare research and diagnostics. Founded in 1937, it is headquartered in Waltham, Massachusetts.